Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Cash from Operations (2020 - 2025)

NeuroPace has reported Cash from Operations over the past 6 years, most recently at 494000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 494000.0 for Q4 2025, up 110.4% from a year ago — trailing twelve months through Dec 2025 was 11006000.0 (up 38.68% YoY), and the annual figure for FY2025 was 11006000.0, up 38.68%.
  • Cash from Operations for Q4 2025 was 494000.0 at NeuroPace, up from 1932000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for NPCE hit a ceiling of 494000.0 in Q4 2025 and a floor of 11393000.0 in Q1 2022.
  • Median Cash from Operations over the past 5 years was 5342500.0 (2021), compared with a mean of 5506650.0.
  • Biggest five-year swings in Cash from Operations: tumbled 91.93% in 2022 and later surged 110.4% in 2025.
  • NeuroPace's Cash from Operations stood at 8203000.0 in 2021, then increased by 4.01% to 7874000.0 in 2022, then soared by 58.08% to 3301000.0 in 2023, then plummeted by 43.87% to 4749000.0 in 2024, then skyrocketed by 110.4% to 494000.0 in 2025.
  • The last three reported values for Cash from Operations were 494000.0 (Q4 2025), 1932000.0 (Q3 2025), and 2068000.0 (Q2 2025) per Business Quant data.